does tirzepatide cause osteoporosis Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity | International Does GLP-1 Affect Bone Density?

Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents

& Alvrez, V

This is manageable with proper collagen support , adequate hydration, and in some cases, dermatological interventions

He cant give an opinion since he doesnt know anything about it